SAT-001

DEVICE2 trials

Sponsors

S-Alpha Therapeutics, Inc.

Conditions

Myopia

Unknown Phase

Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia

RecruitingNCT06344572

S-Alpha Therapeutics, Inc.Myopia

Start: 2023-09-27End: 2025-09-30Target: 110Updated: 2025-08-13

Exploratory Study on the Effect of SAT-001 on Choroidal Thickness in Pediatric Myopia Patients

CompletedNCT06729723

S-Alpha Therapeutics, Inc.Myopia

Start: 2024-08-19End: 2024-12-31Updated: 2025-01-10

Related Papers

Digital therapeutics approach for young children with myopia using SAT-001 (DAYS): study protocol for a randomized controlled trial

Trials2025-04-08